
|Videos|April 14, 2016
What Are The Barriers to HCV Treatment?
Author(s)Contagion Editorial Staff
Charitha Gowda, MD MPH, infectious diseases physician at Penn Presbyterian Medical Center, explains the barriers to hepatitis C (HCV) treatment.
Advertisement
Charitha Gowda, MD MPH, infectious diseases physician at Penn Presbyterian Medical Center, explains the barriers to hepatitis C (HCV) treatment.
Newsletter
Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contagion Live
1
Antifungal Earns FDA QIDP and Fast Track Designations Amid Rising Antifungal Resistance
2
CDC Calculates Continuing Burden from COVID-19 Illnesses
3
ACIP Chair Says Polio Vaccine Should be Optional
4
Top Infectious Disease News Stories Week of January 17 - January 23
5




































































































































